According to the results of the year 2013 total sales of the top five best selling Rx drugs amounted to RUR 1,639.1 million, which corresponds to 44.0% of sales in the Rx drugs segment and 31.1%[1] of the Company's total sales.
According to the results of the year 2013 the top five best selling Rx drugs are:
- Geptor (Ademetionine; ATC[2] «Digestive tract and metabolism»); sales increased by 20.6% as compared to the same period of the previous year; 14.9% of sales in the Rx drugs segment;
- Cerepro (Choline Alfoscerate; ATC «Medications for the treatment of the nervous system diseases»); sales in the segment made 9.6%;
- Tautax (Docetaxel; ATC «Antineoplastic and immunomodulating agents»); sales in the segment made 9.5%;
- Irunine (Itraconazole; ATC «Antimicrobials for systematic use»); sales in the segment made 5.0%;
- Parclitaxel-LENS (Parclitaxel; ATC «Antineoplastic and immunomodulating agents»); sales in the segment made 4.9%;
OTC drugs segment is characterized by the high degree of consolidation. It means that the top five best selling medicines make 98.4% of sales.
- Xilen (Xylometazoline; ATC «Medications for the treatment of respiratory system»); sales in the OTC drugs segment made 49.1%;
- Slabilen (Sodium picosulfate; ATC «Alimentary tract and metabolism»); sales in the OTC drugs segment made 30.0%;
- Motilak (Domperidone; ATC «Alimentary tract and metabolism»); sales in the OTC drugs segment made 15.3%;
- Vitasharm and Vitatress (ATC «Vitamins»); sales in the OTC drugs segment made 3.2%;
- Ginkgo biloba (Ginkgo biloba; ATC «Medications for the treatment of urogenital organs»); sales in the OTC drugs segment made 0.8%.
According to the results of 2013 the top five best selling traditional drugs are:
- Vero-Dexamethasone (Dexamethasone; ATC «Hormonal drugs for systematic use»); sales in the traditional drugs segment made 39.7%;
- Pyridoxine (ATC «Alimentary tract and metabolism»); sales in the segment made 27.6%;
- Vero-Ciprofloxacin (Ciprofloxacin; ATC «Antimicrobials for systematic use»); sales in the segment made 12.4%;
- Vero-Loperamide (Loperamide; ATC «Alimentary tract and metabolism»); sales in the segment made 12.0%;
- Vero-Flukonazole (Fluconazole; ATC «Antimicrobials for systematic use»); sales in the segment made 4.4%;
According to the results of 2013 the top five best selling non-pharamaceutical products are:
- Conventional antimicrobial adhesive bandages; 36.8% of sales in the segment;
- Conventional reel adhesive bandages; 23.2% of sales in the segment;
- Therapeutic patches - pepper plasters; 20.0% of sales in the segment;
- Therapeutic patches - corn plasters; 15.4% of sales in the segment;
- Comida (ATC "Nutritional therapy"); 2.4% of sales in the segment.
During 2013 Veropharm initiated production and sales of new forms and dosages of the following drugs:
- Anfibra (Enoxaparin sodium; ATC «Medications affecting hematogenesis and blood»);
- Salbutamol (Salbutamol; ATC «Medications for the treatment of respiratory system»);
- ACP (Escitolapram, ATC «Medications for the treatment of the nervous system diseases»);
- Gistamel (Imatinib; ATC «Antineoplastic and immunomodulating agents»);
- Vero-Ifosfamide (Ifosfamide; ATC «Antineoplastic and immunomodulating agents»);
- Iriten (Irinotecan; ATC «Antineoplastic and immunomodulating agents»);
- Mielastra (Filgrastim; ATC «Antineoplastic and immunomodulating agents»);
- Bereta (Rabeprazole; ATC «Alimentary tract and metabolism»);
- Motilak (Domperidone; ATC «Alimentary tract and metabolism»);
- GeptorDaily (Ademetionine; ATC «Alimentary tract and metabolism»);
- Timolol-LENS (Timolol; ATC "Medications for the sense organs treatment");
- Vero-Stavudine (Stavudine; ATC «Antimicrobials for systematic use»);
- Betaver (Betahistine; ATC "Medications for the treatment of nervous system");
- Poludan (Polyadenilic acid + Polyuridilic acid; ATC "Medications for the sense organs treatment").
During 2013 Veropharm has initiated the sales of new forms of the following non-pharmaceutical products:
- «Sensex» (Condoms; ATC «Medical items»);
- Sticking plaster "Uniplast" (ATC «Medical items»);
- Sticking plaster "Veroplast" (ATC «Medical items»).
In the year 2013 Veropharm received registration for the following 3 drugs:
- ACP (Escitolapram, ATC «Medications for the treatment of the nervous system diseases»);
- Gistamel (Imatinib; ATC « Antineoplastic and immunomodulating agents»);
- Bixicam (Meloxicam; ATC "Medications for the treatment of the muscularskeletal system diseases").
In the year 2013 the following two substances were included in the State register of medicines and medical products:
- Carboplatin produced by LLC "LENS-Pharm";
- Tropisetron hydrochloride produced by QUILU Pharmaceutical Co. Ltd., China.
In the year 2013 the following non-pharmaceutical products were registered:
- Detoksiver - dietary supplement;
- 14 dietary products for weight control "Nutrico Diet®";
- 9 perfume and cosmetic products.
In the year 2013 the following 3 drugs produced by LLC "LENS-Pharm" were registered in CIS countries:
- Geptaver, lyophilizate for preparation of a solution for intravenous and intramuscular injection 400 mg in the Republic of Belarus (ATC «Alimentary tract and metabolism»);
- CONTRILENS, lyophilizate for preparation of a solution for intravenous injection 10 000 antitrypsin in the Republic of Uzbekistan (proteolysis inhibitor);
- Vero-Methotrexat, solution for injections 5 mg/ml, 10 mg/ml in the Republic of Uzbekistan (ATC "Oncology drug, antimetabolite").
[1] % - percent of finished goods sales
[2] ATC - anatomico-therapeutico-chemical group
Press-release
distributed by |